U-M's Kellogg Center soon to offer "bionic eye"
A retinal implant dubbed a "bionic eye" soon will be available to patients at the University of Michigan's Kellogg Eye Center.
Intended for patients with late stage retinitis pigmentosa, a disease that causes vision loss, the device is inserted in one eye, and the patient wears special glasses with a camera that captures the images and converts them into electrical impulses. The U.S. Food and Drug Administration recently approved the implants, and U-M's Kellogg center will be one of only 13 locations nationwide to offer the device.
Click here to watch a news video about the implant.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
U-M statement on the passing of A. Alfred Taubman
We have lost a dear friend and educational partner, one of the genuine leaders and best.
Taubman Scholars: Reflections on Alfred Taubman
Eminent scientists say his curiosity, interest and vision changed the course of medical science.
news & events
In the News
Taubman Emerging Scholar makes strides against cancer
Erika Newman, M.D., has identified a characteristic of deadly childhood neuroblastoma that may pave the way for more effective treatments.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.